Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
PHASE2CompletedINTERVENTIONAL
Enrollment
266
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Conditions
Actinic Keratosis
Interventions
DRUG
ingenol mebutate
OTHER
Placebo
Trial Locations (1)
Unknown
Long Island Skin Cancer and Dermatologic Surgery, Smithtown